---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-004196"
form_type: "8-K/A"
ticker: "HBIO"
cik: "0001123494"
company_name: "HARVARD BIOSCIENCE INC"
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:31:29.903854+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Harvard Bioscience misses audit committee independence; Nasdaq confirms; cure period through June 2026

## Summary
- Alan Edrick resigned from Board and Audit Committee effective June 10, 2025, leaving only two audit committee members.
- Nasdaq Staff notified Company on June 26, 2025 that it no longer meets Audit Committee Composition Requirement (Rule 5605(c)(2)(A)).
- Company has cure period until earlier of next annual meeting or June 10, 2026 to fill vacancy with independent director.
- Company intends to appoint a new independent Board member expeditiously to regain compliance.

## SEC filing metadata
- accession: 0001171843-25-004196
- form_type: 8-K/A
- ticker: HBIO
- cik: 0001123494
- company_name: HARVARD BIOSCIENCE INC
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1123494/000117184325004196/0001171843-25-004196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1123494/000117184325004196/f8ka_062725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-004196
- JSON: https://secwatch.observer/filing/0001171843-25-004196.json
- Plain text: https://secwatch.observer/filing/0001171843-25-004196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.